Compare DYAI & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYAI | TPCS |
|---|---|---|
| Founded | 1979 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8M | 34.0M |
| IPO Year | 2003 | 2008 |
| Metric | DYAI | TPCS |
|---|---|---|
| Price | $0.68 | $3.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 94.1K | 55.4K |
| Earning Date | 03-25-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $3,090,345.00 | ★ $34,031,000.00 |
| Revenue This Year | $144.41 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $0.65 | $2.08 |
| 52 Week High | $1.43 | $6.25 |
| Indicator | DYAI | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 28.45 |
| Support Level | N/A | $3.14 |
| Resistance Level | $0.97 | $3.91 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.21 | 10.53 |
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.